Search

Your search keyword '"Valster A"' showing total 491 results

Search Constraints

Start Over You searched for: Author "Valster A" Remove constraint Author: "Valster A"
491 results on '"Valster A"'

Search Results

1. Use of iLearning in an Introductory Human Anatomy and Physiology Course

3. Mental Health Prevalence in NCAA Division III Collegiate Athletes

5. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

7. Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

11. EXTENSION OF 2016 WORLD HEALTH ORGANIZATION (WHO) CLASSIFICATION INTO A NEW SET OF CLINICAL, LABORATORY, MOLECULAR, AND PATHOLOGICAL CRITERIA FOR THE DIAGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS: FROM DAMESHEK TO VAINCHENKER, GREEN, AND KRALOVICS

15. Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer

17. Incorporation of the 2008 WHO into 2008/2020 ECMP/CLMP Classification for Staging and Prog-nosis Assessment of JAK2, MPL, TPO, MPL and CALR Mutated Myeloproliferative Neoplasms: From Dameshek to Vainchenker and Michiels 1940 - 2020: A Historical Appraisal and Novel Therapeutic Implications

22. Monitoringsrapportage NSL 2021. Stand van zaken Nationaal Samenwerkingsprogramma Luchtkwaliteit

23. Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

26. Analysis of Clinical, Laboratory and Bone Marrow Features in Dominant TPO, MPL and JAK2 Germline Mutated Hereditary Essential Thrombocythemia (HET) Versus Acquired MPL515, CALR and JAK2V617F Mutated ET in Myeloproliferative Neoplasms

27. Bone marrow histology in CALR mutated thrombocythemia and myelofibrosis: results from two cross sectional studies in 70 newly diagnosed JAK2/MPL wild type thrombocythemia patients

29. Why do people use portable air purifiers? Evidence from occupant surveys and air quality monitoring in homes in three European cities

30. Why do people use portable air purifiers? Evidence from occupant surveys and air quality monitoring in homes in three European cities

31. Monitoringsrapportage NSL 2020 : Stand van zaken Nationaal Samenwerkingsprogramma Luchtkwaliteit

32. Validatie rekenhart AERIUS lucht

33. Aan aquathermie gekoppelde bodemenergiesystemen: Effecten op de ondergrond

34. Quantitative detection of the free-living amoeba 'Hartmannella vermiformis' in surface water by using real-time PCR

36. Novel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and Michiels

37. Incorporation of the 2008 WHO into 2008/2020 ECMP/CLMP Classification for Staging and Prog-nosis Assessment of JAK2, MPL, TPO, MPL and CALR Mutated Myeloproliferative Neoplasms: From Dameshek to Vainchenker and Michiels 1940 - 2020: A Historical Appraisal and Novel Therapeutic Implications

40. Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA)

42. Carbon dioxide as a novel indicator for bacterial growth in milk

43. Decellularized Porcine Achilles Tendon Induces Anti-inflammatory Macrophage Phenotype In Vitro and Tendon Repair In Vivo

46. Treurbuis of 'verantwoord divertissement'?: Vertrossing en televisiekritieken in de jaren '70

47. Why do people use portable air purifiers? Evidence from occupant surveys and air quality monitoring in homes in three European cities.

48. COVID-19 Distress in NCAA Division III Student-athletes.

50. Important loss mechanisms in visible lasers revealed by hydrostatic pressure

Catalog

Books, media, physical & digital resources